Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Hit by Strike, GSK...

    Hit by Strike, GSK Consumer Suspends Ops at Punjab Plant

    Written by savita thakur thakur Published On 2016-05-24T12:49:26+05:30  |  Updated On 24 May 2016 12:49 PM IST
    Hit by Strike, GSK Consumer Suspends Ops at Punjab Plant

    New Delhi : GlaxoSmithKline Consumer Healthcare has suspended operations temporarily at its factory in Nabha Patiala in Punjab effective following disruptions created by its workforce.


    "Due to certain disruptions created by the workforce/ flash strike the management of the company has decided to suspend operations temporarily at its factory located at Nabha Patiala 147201 with effect from the night of May 21, 2016," GSK Consumer Healthcare said in a BSE filing.


    The company added that it took the step "in the interest of safety and security of its employees and to protect the assets of the factory".


    Last week, GlaxoSmithKline (GSK) Consumer Healthcare reported an 8.18 per cent decline in its stand alone net profit for the March quarter at Rs 180.7 crore.


    The company had posted a net profit of Rs 196.8 crore for the corresponding period a year ago.


    Net sales during the period under review was Rs 1,052.8 crore, down 9.63 per cent, from Rs 1,165.1 crore in the same period last fiscal.


    For the full fiscal, GSK's stand-alone net profit rose 17.7 per cent to Rs 686.9 crore as against Rs 583.6 crore in 2014-15.


    However, its net sales declined 0.72 per cent to Rs 4,106.6 crore in 2015-16, from Rs 4,136.4 crore a year ago.


    The stock is trading 0.11 per cent higher at Rs 5,820 on BSE at 1156 hours.

    GlaxoSmithKlineGSKHealthcarepunjab plantsuspended
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok